HIV Infections: all 4,342 studies
Page 32 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral TherapyCompletedNCT00312832Not applicable
- A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic SyndromeTerminatedNCT00312754Phase 4
- Study of Valproic Acid to Treat HIV Infected AdultsTerminatedNCT00312546Phase 1
- Examining the Link Between Heart Disease and HIV Infection in WomenCompletedNCT00312468
- Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)CompletedNCT00312169
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedNCT00312091Phase 1/2
- Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V MutationCompletedNCT00312039Phase 1/2
- Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 StudiesCompletedNCT00311688
- HIV Prevention Within High-Risk Bulgarian and Hungarian Social NetworksCompletedNCT00310973Phase 2/3
- Case-Control Viramune (Nevirapine) Toxicogenomics StudyCompletedNCT00310843
- Zambia Exclusive Breastfeeding StudyCompletedNCT00310726Not applicable
- BASTA Study on STI in HIV Infected PatientsCompletedNCT00310245Phase 3
- A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in BelgiumCompletedNCT00309205Phase 1/2
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
- A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South AfricaWithdrawnNCT00304668Phase 1/2
- A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00304642Phase 1
- A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide GelCompletedNCT00303576Phase 1/2
- Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)CompletedNCT00302822Phase 3
- Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)CompletedNCT00301561Phase 3
- Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy AdultsCompletedNCT00301184Phase 1
- Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIsTerminatedNCT00300573Phase 2
- Evaluation of an HIV Outreach ProgramCompletedNCT00300183
- Engagement in HIV Primary Care ServicesCompletedNCT00300170
- SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsStatus unknownNCT00299897Phase 2
- A Dose Response and Safety Study of Procaine HCl in HIV-Infected PatientsCompletedNCT00299338Phase 1/2
- Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.CompletedNCT00298350Phase 2
- Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00297076Phase 3
- Acute HIV Infection Observational StudyCompletedNCT00296660
- Omacor and Cardiovascular Risk Factors in HIV Patients on HAART TreatmentCompletedNCT00296153Phase 4
- Interaction Between HIV and Lymphatic FilariasisCompletedNCT00295698Not applicable
- An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution SyndromeCompletedNCT00294918Phase 2/3
- Pharmacokinetics Study on Nevirapine Resistance in TanzaniaCompletedNCT00294892Phase 2
- Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated PatientsTerminatedNCT00294372Phase 2
- Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)CompletedNCT00294164Phase 2/3
- Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use MethamphetamineCompletedNCT00291512Phase 2
- Valproic Acid and Its Effects on HIV Latent ReservoirsCompletedNCT00289952Phase 2
- Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected PatientsCompletedNCT00287677Phase 4
- The Use of Nutropin Depot in HIV-infected Adult MalesWithdrawnNCT00286676Phase 2/3
- Directly Observed Therapy in High Risk Populations in Newark, NJCompletedNCT00285883Phase 3
- A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus CapsulesCompletedNCT00281606Phase 4
- Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV TreatmentCompletedNCT00280969Phase 3
- Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDSStatus unknownNCT00280449Phase 1
- Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and EcuadorCompletedNCT00279331
- Traditional CAM Therapy in the Treatment of HIV/AIDSTerminatedNCT00276991Phase 1/2
- 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining StudyCompletedNCT00275444Phase 2
- Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent AdultsCompletedNCT00273988Phase 4
- Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric PatientsCompletedNCT00273975Phase 2
- Highly Active Antiretroviral Therapy (HAART) Adherence InterventionsCompletedNCT00273780Not applicable
- Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMAStatus unknownNCT00273403Not applicable
- PK of Once Daily ART Containing Tenofovir and Atazanavir/RitonavirCompletedNCT00273273
- Life Skills Intervention for Adolescents Perinatally Infected With HIVCompletedNCT00272519Not applicable
- Longitudinal Study of HAART, Social Networks, & AdherenceCompletedNCT00272220Not applicable
- C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention InterventionsCompletedNCT00271908
- Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African AdultsCompletedNCT00270764
- Impact of Anti-HIV Treatment on Labor Productivity and Costs in South AfricaWithdrawnNCT00270725
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyCompletedNCT00270283Phase 2
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) TherapyCompletedNCT00270270Phase 2
- Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected AdultsCompletedNCT00270218Phase 1
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00270010Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00269945Phase 2
- Cardiovascular Risk Factor Management in HIV InfectionCompletedNCT00264394Phase 4
- Can Resistance Enhance Selection of Treatment? (CREST)CompletedNCT00262717Not applicable
- Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV InfectionCompletedNCT00262106Phase 3
- Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular RouteCompletedNCT00261001Phase 1
- Metabolic Abnormalities - HIV Infected and Uninfected MalesCompletedNCT00260936
- Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected ChildrenCompletedNCT00260806
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedNCT00260078Phase 1/2
- Directly Observed Therapy for HIV Infected AdolescentsCompletedNCT00259389Not applicable
- GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected AdultsCompletedNCT00257621Phase 2
- Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV DrugsCompletedNCT00257127Not applicable
- Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIVCompletedNCT00256828Phase 4
- Sleep, HIV Disease Progression, and Function in HIV Infected Children and AdolescentsCompletedNCT00253695
- ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion LeaderCompletedNCT00252109
- ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention TechniquesCompletedNCT00252083Not applicable
- A Pilot Study of LTB4 in HIV-1 Infected AdultsCompletedNCT00251537Phase 2
- Online HIV Prevention Vignette EvaluationCompletedNCT00249327Not applicable
- Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected AdultsCompletedNCT00249106Phase 1
- MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, TanzaniaCompletedNCT00248469Phase 3
- Evaluation of Atazanavir Substitution Intervention (EASI) StudyCompletedNCT00247845
- Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During PregnancyCompletedNCT00246610Phase 4
- TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.Approved for marketingNCT00245739
- Effects of Endocrine Health on Mental Performance of Men and Women Using DrugsCompletedNCT00245531
- Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)CompletedNCT00244803
- Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285WithdrawnNCT00243568Phase 3
- Family-based HIV Prevention for Adolescent GirlsCompletedNCT00243126Not applicable
- The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) StudyCompletedNCT00242957Not applicable
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced AdultsTerminatedNCT00242879Phase 2
- Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)CompletedNCT00242840Phase 3
- The Efficacy of the HIV/AIDS Symptom Management ManualCompletedNCT00241202Not applicable
- Fosamprenavir Expanded AccessCompletedNCT00240552Phase 4
- Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as PromisedCompletedNCT00238459
- Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir ScoreCompletedNCT00234975Phase 4
- Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral TherapyTerminatedNCT00234962Phase 4
- Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve PatientsCompletedNCT00234923Phase 3
- Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected PatientsCompletedNCT00234910Phase 3
- When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
- WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.CompletedNCT00233883Phase 4
- Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected MenCompletedNCT00231972Not applicable
- Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)CompletedNCT00226434Phase 3
- Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System LymphomaCompletedNCT00226304